Chart calendar Novartis AG

30d19cffb96b19dd0881d6.VSkZB4sYgQo3Vz3EvzlHgrl1RMDK3CO8RBZZ-ORUgSo.MxxyZeJ25nlbO2ep-gh0t5Q7K5-ehUvvLEBom5Nht1xtQyFd70u3YAENXg~57e0ad78ff62acfb91bf7663be23df26

Upcoming events on Novartis AG

02/03/2026

TD Cowen Health Care Conference

03/03/2026

UBS European Healthcare Conference

06/03/2026

Annual General Meeting

09/03/2026

Barclays Global Healthcare Conference

09/03/2026

For final dividend

23/03/2026

BNP Paribas Exane Healthcare Conference

24/03/2026

Goldman Sachs Innovation Clinic Conference

27/04/2026

Q1 2026 Earnings Release

20/07/2026

Q2 2026 Earnings Release

26/10/2026

Q3 2026 Earnings Release

02/02/2027

Q4 2026 Earnings Release (Projected)

26/04/2027

Q1 2027 Earnings Release (Projected)

19/07/2027

Q2 2027 Earnings Release (Projected)

25/10/2027

Q3 2027 Earnings Release (Projected)

Past events on Novartis AG

04/02/2026

Q4 2025 Earnings Call

04/02/2026

Q4 2025 Earnings Release

12/01/2026

J.P. Morgan Healthcare Conference

11/12/2025

San Antonio Breast Cancer Symposium - Abstract No - # PS3-09-08

11/12/2025

San Antonio Breast Cancer Symposium - Abstract No - # PS3-09-15

11/12/2025

San Antonio Breast Cancer Symposium - Abstract No - # PS3-08-27

11/12/2025

San Antonio Breast Cancer Symposium - Abstract No - # PD5-10

10/12/2025

San Antonio Breast Cancer Symposium - Abstract No - # PS1-04-17

10/12/2025

San Antonio Breast Cancer Symposium - Abstract No - # PS1-10-27

09/12/2025

American Society of Hematology Meeting - Abstract No - #LBA-2

08/12/2025

American Society of Hematology Meeting - Abstract No - #4981

08/12/2025

American Society of Hematology Meeting - Abstract No - #4978

08/12/2025

American Society of Hematology Meeting - Abstract No - #5549

08/12/2025

American Society of Hematology Meeting - Abstract No - #906

08/12/2025

American Society of Hematology Meeting - Abstract No - #910

08/12/2025

American Society of Hematology Meeting - Abstract No - #844

07/12/2025

American Society of Hematology Meeting - Abstract No - #3198

07/12/2025

American Society of Hematology Meeting - Abstract No - #670

07/12/2025

American Society of Hematology Meeting - Abstract No - #724

06/12/2025

American Society of Hematology Meeting - Abstract No - #1997

Past dividends on Novartis AG

10/03/2025

Annual 3.5 CHF

06/03/2024

Annual 3.3 CHF

08/03/2023

Annual 3.2 CHF

07/03/2022

Annual 3.1 CHF

03/03/2021

Annual 3 CHF

02/03/2020

Annual 2.95 CHF

03/03/2019

Annual 2.85 CHF

05/03/2018

Annual 2.8 CHF

01/03/2017

Annual 2.75 CHF

24/02/2016

Annual 2.7 CHF

02/03/2015

2.6 CHF

26/02/2014

Annual 2.45 CHF

25/02/2013

Annual 2.3 CHF

26/02/2012

Annual 2.25 CHF

23/02/2011

Annual 2.2 CHF

01/03/2010

Annual 2.1 CHF

26/02/2009

Annual 2 CHF

28/02/2008

Annual 1.6 CHF

Annual results

Fiscal PeriodDecember 2023 2024 2025 2026 2027 2028
Net sales
Million USD
Released
Forecast
Spread
46 660
46 810
-0.32%
51 722
50 407
2.61%
56 674
55 618
1.9%

57 354


60 068


63 706

EBITDA
Million USD
Released
Forecast
Spread
17 937
18 223
-1.57%
21 006
19 819
5.99%
23 415
23 681
-1.12%

23 333


25 129


27 076

EBIT
Million USD
Released
Forecast
Spread
16 372
16 735
-2.17%
19 494
18 983
2.69%
21 889
21 846
0.19%

21 860


23 210


25 274

Earnings before Tax (EBT)
Million USD
Released
Forecast
Spread
9 123
10 323
-11.63%
13 640
13 560
0.59%
16 352
17 360
-5.81%

17 696


19 181


21 922

Net income
Million USD
Released
Forecast
Spread
14 854
10 329
43.8%
11 939
11 438
4.38%
13 967
14 570
-4.14%

14 486


15 962


17 844

EPS
USD
Released
Forecast
Spread
7,15
5,38
32.95%
5,92
5,53
7%
7,21
7,16
0.7%

7,56


8,42


9,78

Announcement Date31/01/2431/01/2504/02/26-

Quarterly results

Fiscal PeriodDecember 2024 Q2 2024 Q3 2024 Q4 2025 Q1 2025 Q2 2025 Q3 2025 Q4 2026 Q1 2026 Q2 2026 Q3 2026 Q4 2027 Q1 2027 Q2 2027 Q3 2027 Q4
Net sales
Million USD
Released
Forecast
Spread
12 872
12 319
4.49%
13 172
12 666
4%
13 558
12 823
5.73%
13 620
13 116
3.85%
14 836
14 136
4.95%
14 358
13 866
3.55%
13 860
14 111
-1.78%

13 647


14 283


14 575


14 775


13 820


14 400


14 635


14 755

EBITDA
Million USD
Released
Forecast
Spread






5 294











5 338
4 861
9.81%
























EBIT
Million USD
Released
Forecast
Spread
4 953
4 667
6.12%
5 145
4 892
5.16%
4 859
4 435
9.56%
5 575
5 272
5.75%
5 925
5 827
1.68%
5 460
5 520
-1.08%
4 929
5 010
-1.62%

5 374


5 611


5 610


5 243


5 370


5 575


5 595


5 555

Earnings before Tax (EBT)
Million USD
Released
Forecast
Spread
3 841
3 896
-1.41%
3 385
4 028
-15.96%
3 285
3 478
-5.55%






4 196
4 238
-0.99%



























Net income
Million USD
Released
Forecast
Spread
3 246
2 858
13.59%
3 189
3 197
-0.25%
2 820
2 585
9.08%
3 606
3 255
10.78%
4 024
3 909
2.93%
3 930
3 652
7.61%
2 404
2 414
-0.4%

3 217


3 523


3 500


3 345













EPS
USD
Released
Forecast
Spread
1,60
1,40
14.13%
1,58
1,48
7.03%
1,42
1,30
9.63%
1,83
1,65
10.96%
2,07
1,99
3.77%
2,04
1,87
9.02%
1,26
1,26
0.23%

1,68


1,84


1,83


1,76













Announcement Date18/07/2429/10/2431/01/2529/04/2517/07/2528/10/2504/02/26--------
18/02/2026

Q4 2025 Earnings Release (Projected)

18/02/2026

Q4 2025 Earnings Release (Projected)

18/02/2026

Q4 2025 Earnings Release (Projected)

19/02/2026

Q4 2025 Earnings Release

19/02/2026

Q4 2025 Earnings Release

19/02/2026

Q4 2025 Earnings Release (Projected)

20/02/2026

Q4 2025 Earnings Release

22/02/2026

Q4 2025 Earnings Release

23/02/2026

Q4 2025 Earnings Release

23/02/2026

Q4 2025 Earnings Release (Projected)

Past sector events for Novartis AG

Today

Q4 2025 Earnings Release (Projected)

Today

Q4 2025 Earnings Release

13/02/2026

Q3 2026 Earnings Release

13/02/2026

Q3 2026 Earnings Release

13/02/2026

Q3 2026 Earnings Release

13/02/2026

Q3 2026 Earnings Release

13/02/2026

Q3 2026 Earnings Release

13/02/2026

Q3 2026 Earnings Release

12/02/2026

Q3 2025 Earnings Release

12/02/2026

Q3 2025 Earnings Release

Quarterly revenue - Rate of surprise

Net sales - Rate of surprise

Annual profits - Rate of surprise